Dr. Austin Harris pioneers personalized ketamine therapy with 85% success rate for depression, anxiety, PTSD & chronic pain. NeuroRelief offers integrated mentalDr. Austin Harris pioneers personalized ketamine therapy with 85% success rate for depression, anxiety, PTSD & chronic pain. NeuroRelief offers integrated mental

Los Angeles Clinic Reports 85% Success Rate with Personalized Ketamine Therapy Approach

2026/03/03 16:00
3 min read
For feedback or concerns regarding this content, please contact us at [email protected]

A medical practice in Los Angeles is reporting an 85% success rate in treating conditions ranging from depression to chronic pain through a personalized approach to ketamine therapy. NeuroRelief Ketamine & Infusion Therapy, founded by Dr. Austin Harris, combines intravenous ketamine treatment with integrative care modalities in what the clinic describes as a ‘one-size-fits-one’ philosophy.

Dr. Harris, a board-certified cardiothoracic anesthesiologist with over 12 years of specialized experience in ketamine treatment, has developed customized programs that integrate IV ketamine therapy with NAD+ infusion therapy and micronutrient infusions. Each treatment plan is tailored to the individual’s unique neurology, psychology, personality, physiology, and specific goals. ‘EVERY single person deserves the right to find relief,’ says Dr. Harris. ‘Our mission is to provide hope and healing to individuals who have struggled to find effective treatment through traditional approaches.’

The practice offers what Dr. Harris calls ‘fully integrated’ care, where every patient works one-on-one with professionals who provide training, guidance, and support in implementing sustainable healing practices. This includes mindfulness meditation, mindful cognitive behavioral therapy exercises, and certified integration and recovery coaching. In an unusual commitment to patient care, Dr. Harris provides all patients with seven-day-a-week real-time access to his personal cell phone, serving as a continuous guide throughout their treatment journey.

Dr. Harris earned his Doctor of Medicine degree, Magna Cum Laude, from St. George’s University School of Medicine and completed his anesthesiology residency at the University of California Irvine. He also completed a fellowship in cardiothoracic anesthesiology at the Keck School of Medicine, USC, and is certified in Psychedelic Integration Therapy and Psychedelic-Assisted Psychotherapy through Fluence. With over a decade of experience in cardiac, thoracic, general, and pediatric anesthesiology, Dr. Harris has served as an attending anesthesiologist at major hospitals across Los Angeles.

Beyond his clinical practice, Dr. Harris is a frequent speaker at national psychedelic medicine and ketamine therapy conferences and has become a leading advocate for the safe, effective, and compassionate use of ketamine in modern medicine. His work bridges traditional medical expertise with integrative healing modalities, encompassing advanced cardiac and thoracic anesthesia, perioperative echocardiography, critical care, and integrative approaches to trauma, addiction, and mood disorders. The practice, located in Sherman Oaks, California, was founded in August 2019 and provides what it describes as a safe, supportive environment where individuals can access cutting-edge therapies combined with compassionate, personalized care.

Blockchain Registration, Verification & Enhancement provided by NewsRamp™

This news story relied on content distributed by 24-7 Press Release. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Los Angeles Clinic Reports 85% Success Rate with Personalized Ketamine Therapy Approach.

The post Los Angeles Clinic Reports 85% Success Rate with Personalized Ketamine Therapy Approach appeared first on citybuzz.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.